用户名:  密码:   
网站首页即时通讯活动公告最新消息科技前沿学人动向两岸三地人在海外历届活动关于我们联系我们申请加入
栏目导航 — 美国华裔教授专家网科技动向学人动向
关键字  范围   
 
USC geneticist Marlena Fejzo named one of Time magazine’s 2024 ‘Women of the Year’
2024/3/19 10:35:35 | 浏览:1010 | 评论:0

USC geneticist Marlena Fejzo named one of Time magazine’s 2024 ‘Women of the Year’

Marlena Fejzo of the Keck School of Medicine of USC has been named one of Time magazine’s 2024 “Women of the Year.”(Photo/Christina Gandolfo)


The recognition follows the Keck School of Medicine professor’s recent study that showed that a hormone produced by the fetus triggers nausea and vomiting during pregnancy.

February 21, 2024
By Leigh Hopper
USC geneticist Marlena Fejzo, whose discovery of the cause of morning sickness in pregnancy brought international attention to her work, is one of Time magazine’s 2024 “Women of the Year,” the publication announced Wednesday.

The recognition follows Fejzo’s recent study in Nature that showed that a hormone produced by the fetus — and the mother’s sensitivity to it — triggers nausea and vomiting during pregnancy.

Up to 80% of pregnant women experience morning sickness, more accurately known as pregnancy sickness since it can occur at any time of day. Another 2% are affected by a severe form called hyperemesis gravidarum, or HG, which can cause dehydration, weight loss, electrolyte imbalances and hospitalization.

“Dr. Fejzo’s persistence in understanding HG, and her exceptional research, has advanced our understanding of the biology of HG, which is information that will be used to improve health outcomes for both mothers at risk and their children,” said Christopher Haiman, director of the Center for Genetic Epidemiology at the Keck School of Medicine of USC.

Fejzo’s life’s work
Fejzo, who joined Haiman’s Center for Genetic Epidemiology last year, endured HG herself. For months in 1999, pregnant with her second child, she suffered intense nausea, unable to keep anything down. As she literally starved and became too weak to stand, her doctor floated theories about the cause:It was psychological, a bid for sympathy from her husband or a way to get attention from her parents.

At 15 weeks, she lost the pregnancy.

Finding the cause of her condition became her life’s work.

Despite the severity of the condition — which includes the potential for maternal death — few scientists study it, and, historically, funding is difficult to find. The National Institutes of Health has funded only six hyperemesis studies since 2007. Fejzo, whose day job at UCLA at the time was studying ovarian cancer, chipped away at the HG puzzle during her evenings and weekends.

A major breakthrough
A breakthrough came when the 23andMe DNA testing company agreed, at Fejzo’s request, to include a few questions about hyperemesis in a survey. A few years later, she worked with the company to scan the genetic data of more than 50,000 research participants for genes associated with pregnancy sickness.

The results pointed to a specific gene, one that encodes a hormone called GDF15.

Subsequent work suggested two possible solutions for pregnancy sickness:a treatment that could lower levels of the hormone GDF15 during pregnancy, or a preventive effort that would involve exposing the woman to the hormone before pregnancy.

What’s next? Fejzo is applying for funding to test whether metformin, a drug that increases GDF15 levels and could thus “prime” the patient, could be taken prior to pregnancy and prevent or lower the risk of HG.

A newly formed company, Materna Biosciences, recruited Fejzo as its chief scientific advisor as it develops a GDF15-based drug for HG. Several such drugs are already in clinical trials for cachexia, a condition that causes severe weight loss in patients with cancer.

Fighting bias and looking for a cure
Fejzo is pleased by Time’s “Women of the Year” designation, but she mostly hopes to raise greater awareness about the condition — and find better treatments or a cure.

“There continues to be bias. I spoke to a doctor this week who has a patient hospitalized,” Fejzo said. “Besides him, the whole rest of the team dismissed her inability to eat as depression. As soon as they gave her steroids, her nausea and vomiting lifted, she ate, and immediately her mood improved.

“I hope the recognition from Time inspires more women to go into science because hyperemesis is not the only condition that’s under researched,” Fejzo said. “We just need more women scientists out there.”


相关栏目:『学人动向
李迅雷:对下半年经济形势和市场的通盘思考 2025-07-04 [37]
为什么孩子“窝里横、外面怂”呢?了解美国心理学家依恋理论,你就明白了 2025-07-04 [61]
专家观点 | 美国文理学院:小而美,美在哪里? 2025-07-04 [26]
他19岁辍学,21岁成立非营利组织,用10年清理半个太平洋 2025-07-04 [28]
刘海影:作为保守主义的特朗普主义及其误解 2025-07-04 [24]
张维迎的种子! 2025-07-03 [53]
哈佛商学院专访Anton Korinek:未来2—5年内,AI可能释放出前所未有的生产力红利 2025-07-03 [59]
孙明春:“稳就业”的多维内涵与综合对策 2025-07-03 [51]
凯文凯利:最新5大预言 2025-06-25 [156]
江小涓:尽全力保持经济回升向好势头,三驾马车能用尽用 2025-07-01 [133]
相关栏目更多文章
最新图文:
:学术出版巨头Elsevier 彻查433名审稿人“强迫引用”黑幕 :中国336个国家重点实验室布局 :中澳政府联合出手打击洗钱和逃税漏税 大量中国居民海外账户遭冻结 :摄影师苏唐诗与寂寞百年的故宫对话6年,3万张照片美伦美奂 :大数据分析图解:2019中国企业500强 张梦然:英国惠康桑格研究所:人体内的微生物与出生方式有关 :美众议院将调查华裔部长赵小兰“利用职权为家族谋利“ :UCLA CCS 2019 Fall Quarter Lecture Series Overview
更多最新图文
更多《即时通讯》>>
 
打印本文章
 
您的名字:
电子邮件:
留言内容:
注意: 留言内容不要超过4000字,否则会被截断。
未 审 核:  是
  
关于我们联系我们申请加入后台管理设为主页加入收藏
美国华裔教授专家网版权所有,谢绝拷贝。如欲选登或发表,请与美国华裔教授专家网联系。
Copyright © 2025 ScholarsUpdate.com. All Rights Reserved.